Brookline Capital Management Comments on BIOX Q2 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Equities research analysts at Brookline Capital Management reduced their Q2 2025 earnings per share estimates for Bioceres Crop Solutions in a research report issued on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of $0.14 for the quarter, down from their prior estimate of $0.28. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2025 earnings at $0.02 EPS and FY2025 earnings at $0.16 EPS.

A number of other equities analysts have also weighed in on the stock. Oppenheimer decreased their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 21st. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Roth Mkm lowered their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Finally, Lake Street Capital decreased their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $12.13.

Bioceres Crop Solutions Stock Down 6.1 %

Shares of NASDAQ:BIOX opened at $6.42 on Friday. Bioceres Crop Solutions has a 1 year low of $5.71 and a 1 year high of $14.05. The stock’s 50-day moving average is $7.58 and its 200 day moving average is $9.80. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.86. The company has a market cap of $403.50 million, a PE ratio of 321.16 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same quarter last year, the company posted ($0.07) earnings per share.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently modified their holdings of the business. Oppenheimer & Co. Inc. bought a new position in shares of Bioceres Crop Solutions in the first quarter worth about $139,000. Lazard Asset Management LLC bought a new stake in Bioceres Crop Solutions during the 1st quarter valued at $212,000. Ping Capital Management Inc. bought a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $448,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Bioceres Crop Solutions in the second quarter worth about $472,000. Finally, Dimensional Fund Advisors LP grew its holdings in Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after acquiring an additional 5,341 shares in the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.